SANASana Biotechnology, Inc.

Healthcare
$2.80-32% 1Y

The financials

Sana Biotechnology, Inc. by the numbers

The next results filing is expected around Nov 5, 2026, the same week as a year ago.

Sana Biotechnology, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$65M−$95Mn/a
Net income−$64M−$94Mn/a
Diluted EPS−$0.22−$0.39n/a

Biotechnology

Ranks #129 of 196 by RyuScore

Compare peers
GERN+1.3%
GERON CORP
DNA-1.1%
Ginkgo Bioworks Holdings, Inc.
ACHV-0.69%
ACHIEVE LIFE SCIENCES, INC.
ABUS-2.5%
Arbutus Biopharma Corp
SGP+3.1%
SpyGlass Pharma, Inc.
ANRO+2.0%
Alto Neuroscience, Inc.